Citations

Mayo Clinic

Showing 10 of 108523 citations.

Patient and Physician Satisfaction with Telemedicine for Monitoring Vital Signs
Bratton, Robert L.

Journal of Telemedicine and Telecare | April 21, 2015 | Volume: 7 | Issue: 1_suppl | Pages: 72-73

10.1177/1357633x010070s130 | PMID 11576500 Get It

We evaluated user satisfaction with realtime telemedicine for monitoring vital signs. Over eight weeks, 20 patients and 12 residents in family medicine participated in the study. At the end of the study, the patients and doctors completed a questionnaire detailing satisfaction with the service. Responses were obtained from 18 of the 20 patients and were generally positive: 61 % were comfortable using the system and 94% did not believe that the technology had a negative effect on their relationship with the health-care provider. Eleven physician responses were obtained. Physicians were more uncertain about the benefits of the service: only 45% felt that telemedicine could adequately assess patients, although 82% felt that telemedicine would be an important part of primary-care services. From a user perspective, our study showed that patients were more satisfied with the telemedicine service than were doctors.
Surgical Treatment for Drug-Resistant Epilepsy—Reply
Jobst, Barbara C. , Cascino, Gregory D. , Jobst, Barbara

JAMA | April 21, 2015 | Volume: 313 | Issue: 15 | Pages: 1572

10.1001/jama.2015.2886 | PMID 25898059 Get It

Refractory anemia with ring sideroblasts and RARS with thrombocytosis
Patnaik, Mrinal M. , Tefferi, Ayalew

American Journal of Hematology | April 21, 2015 | Volume: 90 | Issue: 6 | Pages: 549-559

10.1002/ajh.24038 | PMID 25899435 Get It

Disease Overview: Ring sideroblasts (RS) are erythroid precursors with abnormal perinuclear mitochondrial iron accumulation. Two myeloid neoplasms defined by the presence of RS, include refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS‐T).Diagnosis: RARS is a lower risk myelodysplastic syndrome (MDS) with dysplasia limited to the erythroid lineage, <5% bone marrow (BM) blasts and ≥15% BM RS. RARS‐T is a provisional entity in the MDS/MPN (myeloproliferative neoplasm) overlap syndromes, with diagnostic features of RARS, along with a platelet count ≥450 × 10(9)/L and large atypical megakaryocytes similar to those observed in BCR‐ABL1 negative MPN.Mutations and Karyotype: Mutations in the SF3B1 gene are seen in ≥80% of patients with RARS and RARS‐T, and strongly correlate with the presence of BM RS; RARS‐T patients have additional mutations such as, JAK2V617F (∼60%), MPL (<5%), and CALR (<5%). Cytogenetic abnormalities are uncommon in both RARS and RARS‐T.Risk stratification: Most patients with RARS are stratified into lower risk groups by the International Prognostic Scoring System (IPSS) for MDS and the revised IPSS. Disease outcome in RARS‐T is better than that of RARS, but worse than that of essential thrombocytosis. Both RARS and RARS‐T have a low risk of leukemic transformation.Treatment: Anemia and iron overload are complications in both diseases and are managed similar to lower risk MDS. Aspirin therapy is reasonable in RARS‐T, especially in the presence of JAK2V617F, but the value of platelet‐lowering drugs is uncertain. Case reports of RARS‐T therapy with lenalidomide warrant additional studies. Am. J. Hematol. 90:550–559, 2015. © 2015 Wiley Periodicals, Inc.
Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population
Sangaralingham, S. Jeson , McKie, Paul M. , Ichiki, Tomoko , Heublein, Denise M., Chen, Horng H. , Bailey, Kent R. , Redfield, Margaret M. , Rodeheffer, Richard J. , Burnett, John C. , Sangaralingham, S. Jeson , Scott, Christopher G. , McKie, Paul M

Hypertension | April 21, 2015 | Volume: 65 | Issue: 6 | Pages: 1187-1194

10.1161/hypertensionaha.115.05366 | PMID 25895587 Get It

C-type natriuretic peptide (CNP) is an endothelium-derived peptide that is released as a protective mechanism in response cardiovascular injury or disease. However, no studies have investigated circulating CNP, identifying clinical factors that may influence CNP and its relationship to cardiovascular disease in the general population. We studied 1841 randomly selected subjects from Olmsted County, MN (mean age, 63±11 years; 48% men). Plasma CNP was measured by a well-established radioimmunoassay and echocardiography, clinical characterization, and detailed medical record review were performed. We report that CNP circulates at various concentrations (median, 13 pg/mL), was unaffected by sex, was weakly associated by age, and that highest quartile of CNP identified a high-risk phenotype. Subjects with CNP in the highest quartile were associated with increased risk of myocardial infarction (multivariable-adjusted hazard ratio, 1.51; 95% confidence interval, 1.09–2.09; P =0.01) but not heart failure, cerebrovascular accidents, or death during a follow-up of 12 years. Addition of the highest quartile of CNP to clinical variables led to a modest increase in the integrated discrimination improvement for risk of myocardial infarction. In a large community-based cohort, elevated circulating CNP identified a high-risk phenotype that included cardiovascular comorbidities and left ventricular dysfunction, and provided evidence that highest concentrations of CNP potentially has prognostic value in predicting future risk of myocardial infarction. Together, these data from the general population highlight the potential value of CNP and support the need for additional studies to evaluate whether mechanisms regulating CNP could improve outcomes.
The Influence of Microsurgical Training on the Practice of Hand Surgeons
Christensen, Thomas J., Anding, William J., Shin, Alexander Y. , Bishop, Allen, Moran, Steven L. , Anding, William, Christensen, Thomas, Shin, Alexander Y

Journal of Reconstructive Microsurgery | April 20, 2015 | Volume: 31 | Issue: 06 | Pages: 442-449

10.1055/s-0035-1549443 | PMID 25893631 Get It

Pregnancy After Spontaneous Coronary Artery Dissection: A Case Series
Gulati, Rajiv , Rose, Carl H., Best, Patricia J.M. , Tweet, Marysia S. , Hayes, Sharonne N.

Annals of Internal Medicine | April 20, 2015 | Volume: 162 | Issue: 8 | Pages: 598-600

10.7326/l14-0446 | PMID 25894037 Get It

In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD
Delivanis, Danae A. , Montori, Víctor M.

Annals of Internal Medicine | April 20, 2015 | Volume: 162 | Issue: 8 | Pages: JC11

10.7326/acpjc-2015-162-8-011 | PMID 25894044 Get It

Review: In acute respiratory failure, prehospital CPAP reduces mortality and intubation rates
Sen, Ayan

Annals of Internal Medicine | April 20, 2015 | Volume: 162 | Issue: 8 | Pages: JC5

10.7326/acpjc-2015-162-8-005 | PMID 25894050 Get It

Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities
Nelson, Alfred D. , Camilleri, Michael

Therapeutic Advances in Gastroenterology | April 20, 2015 | Volume: 8 | Issue: 4 | Pages: 206-220

10.1177/1756283x15578608 | PMID 26136838 Get It

With the recent introduction and approval of medications directed at the treatment of opioid induced constipation (OIC) in patients with nonmalignant pain, there is increased interest and understanding of the unmet need and opportunities to enhance patient management. The high incidence of OIC is associated with rapid increase of narcotic analgesic prescriptions for nonmalignant chronic pain. This review addresses briefly the mechanisms of action of opioids that lead to OIC, the differential tolerance of gastrointestinal organs to the effects of opioids, the size and scope of the problem, the definition and outcome measures for OIC, current differential diagnosis and management algorithms, and the pharmacology and efficacy of treatments for OIC in patients with nonmalignant pain.
A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010
Gerber, Yariv , Weston, Susan A., Redfield, Margaret M. , Chamberlain, Alanna M. , Manemann, Sheila M., Jiang, Ruoxiang , Killian, Jill M. , Roger, Véronique L. , Chamberlain, Alanna M

JAMA Internal Medicine | April 20, 2015 | Volume: 175 | Issue: 6 | Pages: 996

10.1001/jamainternmed.2015.0924 | PMID 25895156 Get It